文章名稱引用次數(shù)

• Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years15
• Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase Randomized, Double-Blind Clinical Trials10
• Artificial Intelligence for the Objective Evaluation of Acne Investigator Global Assessment9
• Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis8
• Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis8
• Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label Study8
• Facial Safe Zones for Soft Tissue Filler Injections: A Practical Guide7
• A Phase Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris6
• A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair6
• Hybrid Fractional Laser: A Multi-Center Trial on the Safety and Efficacy for Photorejuvenation5